B-hCD20 EL4_Biocytogen Pharmaceuticals (Beijing) Co., Ltd._Biocytogen, drug development, antibody discovery

Please input keywords

Order

*Country

한국

미국

일본

중국

영국

호주

프랑스

독일

이탈리아

싱가포르

인도

러시아

캐나다

스위스

기타 국가

*Province

*City

*Name

*Telephone

*Company

*Position

*Email

*Verification code

*Verification Code

B-hCD20 EL4

Common name	B-hCD20 EL4	Catalog number	310717
Aliases	MS4A1, Bp35, CVID5	Disease	Lymphoma
Organism	Mouse	Strain	C57BL/6N
Tissue types	Lymphoma	Tissue	T lymphocyte

Description

The human CD20 coding sequence was inserted into the ROSA26 locus in EL4 cells. Human CD20 is highly expressed on the surface of B-hCD20 EL4 cells.

Application

B-hCD20 EL4 cells have the capability to establish tumors in vivo and can be used for efficacy studies.

Targeting strategy

Gene targeting strategy for B-hCD20 EL4 cells. The exogenous promoter and human CD20 coding sequence was inserted into the ROSA26 locus in murine.

Protein expression analysis

CD20 expression analysis in B-hCD20 EL4 cells by flow cytometry. Single cell suspensions from wild-type EL4 and B-hCD20 EL4 cultures were stained with species-specific anti-CD20 antibody. Human CD20 was detected on the surface of B-hCD20 EL4 cells but not wild-type EL4 cells. The 2-E06 clone of B-hCD20 EL4 cells was used for in vivo experiments.

Tumor growth curve & Body weight changes

Subcutaneous homograft tumor growth of B-hCD20 EL4 cells. B-hCD20 EL4 cells (2x10⁵) and wild-type EL4 cells (2x10⁵) were subcutaneously implanted into C57BL/6N mice (female, 6-9-week-old, n=6). Tumor volume and body weight were measured twice a week. (A) Average tumor volume ± SEM. (B) Body weight (Mean± SEM). Volume was expressed in mm³ using the formula: V=0.5 X long diameter X short diameter². As shown in panel A, B-hCD20 EL4 cells were able to establish tumors in vivo and can be used for efficacy studies.Animals with tumor volume over 3000mm³ in the control group were euthanized.